Rank | Citation | Title | First author | Year | Journal |
---|---|---|---|---|---|
A. Top 10 references in cluster0 “myocardial fibrosis” | |||||
1 | 54 | Cardiac fibrosis: the fibroblast awakens. | Travers JG | 2016 | Circ Res |
2 | 48 | Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. | Frangogiannis NG | 2019 | Mol Aspects Med |
3 | 43 | Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis. | Khalil H | 2017 | J Clin Invest |
4 | 37 | Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity. | Jia GH | 2018 | Circ Res |
5 | 35 | Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. | Fu X | 2018 | J Clin Invest |
6 | 32 | Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives. | González A | 2018 | J Am Coll Cardiol |
7 | 25 | Cardiac fibrosis. | Frangogiannis NG | 2021 | Cardiovasc Res |
8 | 23 | Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration | Talman V | 2016 | Cell Tissue Res |
9 | 22 | Revisiting Cardiac Cellular Composition | Pinto AR | 2016 | Circ Res |
10 | 22 | Heart Disease and Stroke Statistics— 2019 Update A Report From the American Heart Association | Benjamin EJ | 2019 | Circulation |
B. Top 10 references in cluster 1“congestive heart failure” | |||||
1 | 19 | The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure. | Pitt B | 1999 | New Engl J Med |
2 | 13 | Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction. | Pitt B | 2003 | New Engl J Med |
3 | 7 | Atrial Extracellular Matrix Remodeling and the Maintenance of Atrial Fibrillation. | Xu J | 2004 | Circulation |
4 | 6 | Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure. | Zannad F | 2000 | Circulation |
5 | 6 | Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. | Boldt A | 2004 | Heart |
6 | 6 | Aldosterone Production Is Activated in Failing Ventricle in Humans. | Mizuno Y | 2001 | Circulation |
7 | 6 | Aldosterone in congestive heart failure. | Weber KT | 2001 | New Engl J Med |
8 | 5 | Aldosterone induces a vascular inflammatory phenotype in the rat heart. | Rocha R | 2002 | Am J Physiol-Heart C |
9 | 5 | Molecular Mechanisms of Myocardial Remodeling. | Swynghedauw B | 1999 | Physiol Rev |
10 | 5 | Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-β1. | Verheule S | 2004 | Circ Res |